Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes

OBJECTIVE: Early results of a randomised trial showed reduced fibrosis due to recurrent HCV hepatitis with tacrolimus triple therapy (TT) versus monotherapy (MT) following transplantation for HCV cirrhosis. We evaluated the clinical outcomes after a median 8 years of follow-up, including differences...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Manousou, Pinelopi, Cholongitas, Evangelos, Samonakis, Dimitrios, Tsochatzis, Emmanuel, Corbani, Alice, Dhillon, A P, Davidson, Janice, Rodríguez-Perálvarez, Manuel, Patch, D, O'Beirne, J, Thorburn, D, Luong, TuVinh, Rolles, K, Davidson, Brian, McCormick, P A, Hayes, Peter, Burroughs, Andrew K
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2014
Aiheet:
Hepatology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4033276/
https://ncbi.nlm.nih.gov/pubmed/24131637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2013-305606
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia